| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0016-5085(97)70071-4 |
| P698 | PubMed publication ID | 9136822 |
| P50 | author | Wen-Jeng Lee | Q58437585 |
| P2093 | author name string | T H Wang | |
| J T Lin | |||
| H P Wang | |||
| M S Wu | |||
| C T Shun | |||
| J C Sheu | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Helicobacter pylori | Q180556 |
| P304 | page(s) | 1457-1465 | |
| P577 | publication date | 1997-05-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection | |
| P478 | volume | 112 |
| Q36631514 | A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy |
| Q36085663 | A concordant expression pattern of fatty acid synthase and membranous human epidermal growth factor receptor 2 exists in gastric cancer and is associated with a poor prognosis in gastric adenocarcinoma patients |
| Q36732888 | A germline variant N375S in MET and gastric cancer susceptibility in a Chinese population |
| Q36726145 | AA-PMe, a novel asiatic acid derivative, induces apoptosis and suppresses proliferation, migration, and invasion of gastric cancer cells |
| Q34554455 | Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. |
| Q64103622 | Association of Gene Mutation With Infection in Gastric Cancer Patients and Its Correlation With Clinicopathological and Environmental Factors |
| Q45187256 | Association of the -160 C --> a promoter polymorphism of E-cadherin gene with gastric carcinoma risk |
| Q54618200 | Clinicopathological significance of loss of heterozygosity in intestinal- and solid-type gastric carcinomas: a comprehensive study using the crypt isolation technique. |
| Q35837213 | Colon cancer: genomics and apoptotic events |
| Q34010863 | Concurrent overexpression of serum p53 mutation related with Helicobacter pylori infection. |
| Q35789245 | Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway |
| Q36267679 | Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer |
| Q45742163 | Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations |
| Q53397820 | Expression of hepatocyte growth factor, transforming growth factor alpha, apoptosis related proteins Bax and Bcl-2, and gastrin in human gastric cancer. |
| Q36623407 | Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer |
| Q42090599 | Gastric adenocarcinoma: clinicopathologic differences among Hispanics and non-Hispanic whites. A single Institution's experience over 14 years |
| Q73738910 | Gastric cancer |
| Q48010134 | Genomic profiling of gastric cancer predicts lymph node status and survival |
| Q34223664 | HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature |
| Q34730196 | Helicobacter pylori infection and molecular changes in gastric carcinogenesis |
| Q53392454 | Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions. |
| Q35059712 | Helicobacter pylori infection in relation to E-cadherin gene promoter polymorphism and hypermethylation in sporadic gastric carcinomas. |
| Q73131528 | Helicobacter pylori-related and -non-related gastric cancers do not differ with respect to chromosomal aberrations |
| Q44867167 | Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas |
| Q37348746 | High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers |
| Q57786534 | Loss of heterozygosity at 18q21 region in gastric cancer involves a number of cancer-related genes and correlates with stage and histology, but lacks independent prognostic value |
| Q35666332 | MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib |
| Q36502563 | Mitochondrial microsatellite instability in gastric cancer and its precancerous lesions |
| Q33816796 | Molecular biology of gastric carcinoma: from laboratory to bedside. |
| Q33789680 | Molecular epidemiology, pathogenesis and prevention of gastric cancer |
| Q43066602 | Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions:H.pylori infection, histological types and staging |
| Q36308958 | Mutation analysis of APC gene in gastric cancer with microsatellite instability |
| Q37520516 | Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer |
| Q35764997 | NEU overexpression in the furan rat model of cholangiocarcinogenesis compared with biliary ductal cell hyperplasia. |
| Q34637700 | Overexpression of CD151 predicts prognosis in patients with resected gastric cancer |
| Q43700580 | Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study |
| Q24802941 | Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer |
| Q41135484 | RAD51 G135C genetic polymorphism and their potential role in gastric cancer induced by Helicobacter pylori infection in Bhutan |
| Q39414766 | RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells. |
| Q37730020 | Selection criteria for c-Met-targeted therapies: emerging evidence for biomarkers |
| Q54235676 | TGF-α gene variations and increased susceptibility of gastric cancer in an Eastern Chinese Han population. |
| Q35078746 | TP53 and gastric carcinoma: a review |
| Q37941807 | Targeting the HER2 pathway for the therapy of lower esophageal and gastric adenocarcinoma |
| Q36127679 | The clinicopathologic association of c-MET overexpression in Iranian gastric carcinomas; an immunohistochemical study of tissue microarrays |
| Q38166450 | The regulation of gastric acid secretion - clinical perspectives |
| Q34103663 | Tyrosine kinases and gastric cancer |
| Q53392449 | p53 mutation pattern and expression of c-erbB2 and c-met in gastric cancer: relation to histological subtypes, Helicobacter pylori infection, and prognosis. |
Search more.